Manchester University NHS Foundation Trust and Medtronic intend to co-develop new health technology for robotic surgery and artificial intelligence.
Manchester University NHS Foundation Trust has strengthened its partnership with medical technology company Medtronic to co-develop new health technology with a focus on robotic surgery and artificial intelligence (AI).
The two organisations have signed a UK-first Research, Development and Innovation collaboration agreement to streamline the collaboration process on mutually beneficial research and innovation projects in four main areas: cardiovascular, neuroscience, medical surgery and diabetes.
“This collaboration provides a huge opportunity to pioneer breakthroughs in healthcare and accelerate our joint projects to design and deliver innovative research that will really make a difference in the NHS, to benefit people in Greater Manchester and beyond,” said Katherine Boylan, deputy managing director of research and innovation at the Trust.
Innovation development
The partnership will be supported by the Trust’s clinical data science unit, which transforms anonymised clinical data for public and professional benefit. This data will support the development of new innovations.
The partnership will also provide opportunities for the Trust’s existing hosted infrastructure, including the National Institute for Health and Care Research (NIHR) HealthTech Research Centre (HRC) in emergency and acute care, with the strategic focus to use new technology to meet governmental shifts towards community and digital by increasing remote patient monitoring and community-based care, complimented by Medtronic’s product portfolio.
“By co-developing novel solutions in cardiovascular, neuroscience, medical surgery, and diabetes, we aim to accelerate the transformation of healthcare and improve patient outcomes,” said Matthew Williams-Grey, senior director of the UK and Ireland at Medtronic.
The new agreement between the Trust and Medtronic develops their existing partnership, which has piloted medical technology like TriageHP Plus, a remote heart monitoring pathway which targets the number of hospitalisations due to heart failure.
